In simpler terms: the molecule is engineered to mimic the portion of growth hormone that appears to drive fat metabolism (lipolysis, fat breakdown) without engaging the full spectrum of growth hormone effects (such as stimulating insulin-like growth factor 1 (IGF-1) or promoting generalized tissue growth)
and belongs to a class of drugs called glucagon-like peptide-1(GLP-1) receptor agonists [2]
Prior to initiating GLP-1 RAs, clinicians should use screening tools such as the Screening, Brief Intervention, and Referral to Treatment for Eating Disorders for adults and the Stanford-Washington University Eating Disorder screen for college-aged students to detect ED risk, added Cynthia Bulik, PhD, distinguished professor of EDs, Department of Psychiatry, School of Medicine, and founding director, UNC Center of Excellence for Eating Disorders, University of North Carolina at Chapel Hill
How do the mechanisms of action for Semaglutide and Tirzepatide compare
It may help improve circulation by becoming a precursor to nitric oxide, a compound in the body that helps relax blood vessels